Neurogene (NGNE) Other Non-Current Assets (2013 - 2026)
Neurogene (NGNE) reported Other Non-Current Assets of $1.11 million for Q2 2026, up 1.0% from $1.1 million a year earlier and up 2.7% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Other Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Neurogene posted Other Non-Current Assets of $1.03 million, up 5.9% from FY2024.
- Other Non-Current Assets has a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
- By year, Other Non-Current Assets came in at $975,000 in FY2024 (+27.6%), $764,000 in FY2023 and $1.93 million in FY2021 (+0.1%).
- The Q2 2026 figure ranks as the highest quarterly Other Non-Current Assets since Q3 2022.
- Year over year, Other Non-Current Assets has now increased in each of the last nine quarters, with growth averaging 24.9% over the last eight quarters.
- The high point for year-over-year Other Non-Current Assets in five years was Q3 2021 (growth of 99.4%); the low point was Q2 2023 (a decline of 73.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.08 million (Q1 2026), $1.03 million (Q4 2025) and $1.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Neurogene | 627.40 Mn | 627.40 Mn | - | 1.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 896,000.00 |
| Dec 31, 2024 | 975,000.00 |
| Sep 30, 2024 | 789,000.00 |
| Jun 30, 2024 | 794,000.00 |
| Mar 31, 2024 | 743,000.00 |
| Dec 31, 2023 | 764,000.00 |
| Sep 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 529,000.00 |
| Mar 31, 2023 | 905,000.00 |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 1.93 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 1.93 Mn |
API Access
Neurogene Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();